NTRK1 and cancer: Since the receptor tyrosine kinase, Axl, is overexpressed in many different types of cancer, we tested if we can design a humanized single chain variable fragment (scFv) against Axl that can be used for cellular immunotherapy, especially in the context of CAR and synNotch receptor.